GB0721131D0 - "Peptide and users thereof" - Google Patents

"Peptide and users thereof"

Info

Publication number
GB0721131D0
GB0721131D0 GBGB0721131.1A GB0721131A GB0721131D0 GB 0721131 D0 GB0721131 D0 GB 0721131D0 GB 0721131 A GB0721131 A GB 0721131A GB 0721131 D0 GB0721131 D0 GB 0721131D0
Authority
GB
United Kingdom
Prior art keywords
peptide
users
fragments
chromogranin
tropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0721131.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Priority to GBGB0721131.1A priority Critical patent/GB0721131D0/en
Publication of GB0721131D0 publication Critical patent/GB0721131D0/en
Priority to PCT/GB2008/003637 priority patent/WO2009053725A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to fragments of Chromogranin A (CgA) derived peptide fragments and their use in methods of therapy, for example in the treatment of diabetes etc. The peptides, for example AL-11, GV-19 and WE-14, are tropic, i.e stimulate release of regulatory substances and may be used in the absence of a stimulatory concentration of glucose.
GBGB0721131.1A 2007-10-27 2007-10-27 "Peptide and users thereof" Ceased GB0721131D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0721131.1A GB0721131D0 (en) 2007-10-27 2007-10-27 "Peptide and users thereof"
PCT/GB2008/003637 WO2009053725A2 (en) 2007-10-27 2008-10-27 Peptides and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0721131.1A GB0721131D0 (en) 2007-10-27 2007-10-27 "Peptide and users thereof"

Publications (1)

Publication Number Publication Date
GB0721131D0 true GB0721131D0 (en) 2007-12-05

Family

ID=38830077

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0721131.1A Ceased GB0721131D0 (en) 2007-10-27 2007-10-27 "Peptide and users thereof"

Country Status (2)

Country Link
GB (1) GB0721131D0 (en)
WO (1) WO2009053725A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20091125A1 (en) * 2009-06-25 2010-12-26 San Raffaele Centro Fond USE OF CROMOGRANIN A AND ITS PEPTIDIC DERIVATIVES IN THE TREATMENT OF CHANNEL INFLAMMATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224982A1 (en) * 2001-07-05 2003-12-04 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
AU2006213607A1 (en) * 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Llc GIP analog and hybrid polypeptides with selectable properties

Also Published As

Publication number Publication date
WO2009053725A2 (en) 2009-04-30
WO2009053725A3 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
HK1145070A1 (en) Therapeutic use of a growth factor, metrnl
MX2010008206A (en) Methods and compositions using klotho-fgf fusion polypeptides.
PH12014501736A1 (en) Therapeutic use of p75ntr neurotrophin binding protein
TW200637574A (en) Treatment method
SG161259A1 (en) Method for treatment of constipation-predominant irritable bowel syndrome
MX343360B (en) Peptide conjugates of glp-1 receptor agonists and gastrin and their use.
CO6180433A2 (en) LINGO LINK MOLECULES AND PHARMACEUTICAL USE OF THE SAME
MX2009005466A (en) Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir.
MX346450B (en) Compositions and methods for treatment of celiac disease.
SG155054A1 (en) Human anti- neutralizing antibodies as selective pathway inhibitors
MX2011010390A (en) Polymer-agent conjugates, particles, compositions, and related methods of use.
TW200701977A (en) Novel use of peptide compounds for treating pain in painful diabetic neuropathy
EP2759302A3 (en) 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour
MX2008012748A (en) A process for concentration of a polypeptide.
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
HK1143992A1 (en) Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment
EP2166845A4 (en) Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
EP2195331A4 (en) Synthetic apolipoprotein e mimicking polypeptides and methods of use
WO2009106819A3 (en) Biological materials and uses thereof
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
WO2006103494A3 (en) Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
SI1869185T1 (en) Conjugate comprising p21 protein for the treatment of cancer
GB0418388D0 (en) Cell therapy
GB0721131D0 (en) "Peptide and users thereof"
UA105940C2 (en) Drug formulation with theobromine and opiate for treatment of cough

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)